The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial.
- 2025-08-18
- RCT · n = 80
- BMC nephrology 26(1)
- Amira Reda Muhammad Galal
- Nahla Mohamed Teama
- Karema Abu-Elfotuha
- Ahmed D Alatawi
- Hanan Alshareef
- Ahmed M E Hamdan
- Ahmed Aljabri
- Mohannad Alshibani
- Zeinab AlKasaby Mahmoud Zalat
- PubMed: 40826392
- DOI: 10.1186/s12882-025-04399-3
- High evidence
- Clinical
There was a significant improvement in renal function biochemical parameters and a significant reduction in the FAS for the intervention groups compared to the control group.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- therapeutic dose